Evidence map›Paper›PMID 40169764›Full record

ArticleLeukemia2025

Correction: Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis.

Daniele Capitanio, Francesca R Calledda, Vittorio Abbonante, Daniele Cattaneo, Manuela Moriggi, Niccolò Bartalucci, Cristina Bucelli, Delfina Tosi, Umberto Gianelli, Alessandro Maria Vannucchi and 4 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Daniele Capitanio *Department of Biomedical Sciences for Health, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0001-7701-728X
Francesca R Calledda *Department of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID http://orcid.org/0009-0006-3234-0538
Vittorio AbbonanteDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.
Daniele CattaneoHematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Manuela MoriggiDepartment of Biomedical Sciences for Health, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-4718-0307
Niccolò BartalucciDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID http://orcid.org/0000-0002-9328-3948
Cristina BucelliHematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Delfina TosiDepartment of Health Sciences, University of Milan, S.C. di Anatomia Patologica, ASST-Santi Paolo e Carlo, Milan, Italy.
Umberto GianelliDepartment of Health Sciences, University of Milan, S.C. di Anatomia Patologica, ASST-Santi Paolo e Carlo, Milan, Italy.
Alessandro Maria VannucchiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.ORCID http://orcid.org/0000-0001-5755-0730
Alessandra IurloHematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Cecilia GelfiDepartment of Biomedical Sciences for Health, University of Milan, Milan, Italy.
Alessandra BalduiniDepartment of Molecular Medicine, University of Pavia, Pavia, Italy. alessandra.balduini@unipv.it.ORCID http://orcid.org/0000-0003-3145-1245
Alessandro MalaraDepartment of Molecular Medicine, University of Pavia, Pavia, Italy. alessandro.malara@unipv.it.ORCID http://orcid.org/0000-0002-3396-3693

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40169764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.